Cargando…
Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
OBJECTIVE: Malignant gliomas are the most common primary tumors of the central nervous system and the prognosis of patients with gliomas is poor. The combination of interferon-bata (IFN-β) and temozolomide (TMZ) has shown significant additive antitumor effects in human glioma xenograft models. Consi...
Autores principales: | Park, Jae-Hyun, Ryu, Chung Heon, Kim, Mi Jin, Jeun, Sin-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Neurosurgical Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479712/ https://www.ncbi.nlm.nih.gov/pubmed/26113958 http://dx.doi.org/10.3340/jkns.2015.57.5.323 |
Ejemplares similares
-
Memantine Induces NMDAR1-Mediated Autophagic Cell Death in Malignant Glioma Cells
por: Yoon, Wan-Soo, et al.
Publicado: (2017) -
Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2018) -
Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells
por: Ryu, Chung Heon, et al.
Publicado: (2013) -
Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
por: Bikhezar, Fatima, et al.
Publicado: (2019) -
Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)